DR Olaf Rusoke-Dierich
Executive Director and Founder of JD Sanmed, Inventor of iXope
MBBS, PhD, FRACGP
Dr Olaf Rusoke-Dierich graduated in medicine from Freie University Berlin, Germany in 1998 and also holds a PhD from Ludwig Maximillian-University Munich Germany in 2007.
Olaf has a diverse medical background. Additionally, he is the author of several books and articles. He is also co-founder and governance consultant at We2Care, a company in Townsville that specialises in providing disability and aged care services.
In 2018 he became the founder and director of JD Sanmed, a company developing innovative medical devices. Olaf’s patented invention is the iScope.
He has a strong interest in exploring clinical solutions that lead to innovations and have practical applications in the medical field. JD Sanmed nurtures his creative skills and drive to explore new solutions that will improve medical care and service delivery in the medical sector.
Judith Rusoke-Dierich
Non-Executive Director
Judith has a Masters of Social Work Studies and Bachelor of Social Science (Development) from the University of Queensland.
She worked as a health clinician in health care systems overseas and in Australia and owned a start-up in retail with a successful exit before founding We2Care in 2018. Judith is currently CEO of We2Care, a rapidly growing provider of disability and aged care services in the Townsville region and Brisbane.
Judith combines her management and operational skills with strong compassion to benefit her staff and clients and the profitable and sustainable growth of the company. She brings in her expertise in management to benefit JD Sanmed.
Ontogo
Commercialization and scaling Australian Health Technology innovation
Ontogo is an independent supporter of Australian innovation with focus on building successful businesses around Australian innovation. Ontogo provides expertise in commercializing and scaling Australian Health Technology innovation locally and internationally.
Ontogo‘s experienced executive consultants are committed to work together with JD Sanmed and support the transition to a permanent team for a successful launch to the global market.